Q&A: Considerations for arrhythmia risk management after COVID-19 infection
COVID-19 linked to cardiac arrhythmias and autonomic dysfunction, even post-infection. AHA issued a scientific statement detailing management strategies, emphasizing AF as the most common arrhythmia, with elevated risk persisting for at least a year. Vaccination does not increase arrhythmia risk, but drug interactions with treatments like nirmatrelvir-ritonavir are crucial to monitor.
© Copyright 2024. All Rights Reserved by MedPath